Acacia Appoints Non-Executive Chair
This article was originally published in Scrip
Executive Summary
Acacia Pharma Group Plc. has appointed Patrick Vink non-executive chair succeeding Ian Kent – effective Dec. 31, 2015. Most recently Vink was chief operating officer of Cubist Pharmaceuticals and prior to this he held senior roles at Mylan Inc. Previously Vink has held various leadership positions at Novartis Sandoz, Sanofi and Biogen and currently he is non-executive director of Inhibikase Inc. and Micreos BV.